Cell signalling

Current research projects

  • The control of sarcoma cell metastasis through the novel AFAP1L1 pathway.
  • The control of red blood cell longevity and integrity through Lyn/Src Family Kinase pathways.
  • Identifying new therapy options for sarcoma patients through personalized genomic medicine.
  • Studying the magnitude of the effect of enzyme variations on the ability of young cancer patients to handle High-Dose-Methotrexate (HDMTX) treatment, as HDMTX can causes severe toxicities.
  • Using personalized genomic medicine to identify potential new therapeutic potions for sarcoma patients.
Back To Top